MRSN
Price
$0.37
Change
-$0.00 (-0.00%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
45.7M
62 days until earnings call
NNVC
Price
$1.50
Change
-$0.07 (-4.46%)
Updated
Jun 5, 04:57 PM (EDT)
Capitalization
23.95M
90 days until earnings call
Interact to see
Advertisement

MRSN vs NNVC

Header iconMRSN vs NNVC Comparison
Open Charts MRSN vs NNVCBanner chart's image
Mersana Therapeutics
Price$0.37
Change-$0.00 (-0.00%)
Volume$32.57K
Capitalization45.7M
NanoViricides
Price$1.50
Change-$0.07 (-4.46%)
Volume$100
Capitalization23.95M
MRSN vs NNVC Comparison Chart
Loading...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRSN vs. NNVC commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRSN is a StrongBuy and NNVC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (MRSN: $0.37 vs. NNVC: $1.49)
Brand notoriety: MRSN and NNVC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRSN: 45% vs. NNVC: 61%
Market capitalization -- MRSN: $45.7M vs. NNVC: $23.95M
MRSN [@Biotechnology] is valued at $45.7M. NNVC’s [@Biotechnology] market capitalization is $23.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRSN’s FA Score shows that 0 FA rating(s) are green whileNNVC’s FA Score has 0 green FA rating(s).

  • MRSN’s FA Score: 0 green, 5 red.
  • NNVC’s FA Score: 0 green, 5 red.
According to our system of comparison, NNVC is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRSN’s TA Score shows that 6 TA indicator(s) are bullish while NNVC’s TA Score has 5 bullish TA indicator(s).

  • MRSN’s TA Score: 6 bullish, 3 bearish.
  • NNVC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MRSN is a better buy in the short-term than NNVC.

Price Growth

MRSN (@Biotechnology) experienced а +5.07% price change this week, while NNVC (@Biotechnology) price change was -10.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

MRSN is expected to report earnings on Aug 06, 2025.

NNVC is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRSN($45.7M) has a higher market cap than NNVC($23.9M). NNVC YTD gains are higher at: 9.790 vs. MRSN (-74.196). NNVC has higher annual earnings (EBITDA): -8.59M vs. MRSN (-63.27M). MRSN has more cash in the bank: 135M vs. NNVC (3.96M). NNVC has less debt than MRSN: NNVC (1.5M) vs MRSN (28.6M). MRSN has higher revenues than NNVC: MRSN (40.5M) vs NNVC (0).
MRSNNNVCMRSN / NNVC
Capitalization45.7M23.9M191%
EBITDA-63.27M-8.59M736%
Gain YTD-74.1969.790-758%
P/E RatioN/AN/A-
Revenue40.5M0-
Total Cash135M3.96M3,411%
Total Debt28.6M1.5M1,907%
FUNDAMENTALS RATINGS
MRSN vs NNVC: Fundamental Ratings
MRSN
NNVC
OUTLOOK RATING
1..100
1878
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
9548
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NNVC's Valuation (37) in the Biotechnology industry is somewhat better than the same rating for MRSN (88). This means that NNVC’s stock grew somewhat faster than MRSN’s over the last 12 months.

NNVC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MRSN (100). This means that NNVC’s stock grew similarly to MRSN’s over the last 12 months.

NNVC's SMR Rating (95) in the Biotechnology industry is in the same range as MRSN (99). This means that NNVC’s stock grew similarly to MRSN’s over the last 12 months.

NNVC's Price Growth Rating (48) in the Biotechnology industry is somewhat better than the same rating for MRSN (95). This means that NNVC’s stock grew somewhat faster than MRSN’s over the last 12 months.

NNVC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MRSN (100). This means that NNVC’s stock grew similarly to MRSN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRSNNNVC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 17 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
W44.291.31
+3.05%
Wayfair
DOMO13.680.30
+2.24%
Domo
VSCO20.470.20
+0.99%
Victoria's Secret & Co
MMM146.81-1.32
-0.89%
3M Company
ICAD3.77-0.13
-3.33%
iCAD

MRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with IGMS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
+5.79%
IGMS - MRSN
56%
Loosely correlated
+0.80%
CRNX - MRSN
48%
Loosely correlated
+0.78%
DYN - MRSN
47%
Loosely correlated
+1.06%
RGNX - MRSN
44%
Loosely correlated
-0.49%
NTLA - MRSN
42%
Loosely correlated
-0.26%
More

NNVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NNVC has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NNVC jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNVC
1D Price
Change %
NNVC100%
+6.80%
MDGL - NNVC
34%
Loosely correlated
-1.79%
ZNTL - NNVC
34%
Loosely correlated
+10.29%
CGEM - NNVC
32%
Poorly correlated
+1.23%
TYRA - NNVC
32%
Poorly correlated
+6.32%
CYTK - NNVC
31%
Poorly correlated
+1.28%
More